{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:20:23Z","timestamp":1790432423502,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.exppara.2019.107793","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T11:18:19Z","timestamp":1573211899000},"page":"107793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo"],"prefix":"10.1016","volume":"208","author":[{"given":"Sanaa S.","family":"Botros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa M.","family":"El-Lakkany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed H.","family":"Seif el-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Nasser","family":"Sabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat A.","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry P.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2019.107793_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40249-017-0286-2","article-title":"Controlling schistosomiasis with praziquantel: how much longer without a viable alternative? Infect","volume":"6","author":"Bergquist","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.exppara.2019.107793_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the African trypanosome Trypanosoma brucei","volume":"309","author":"Berriman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.exppara.2019.107793_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5414\/CPP49051","article-title":"High absolute bioavailability of the new oral phosphodiesterase-4 inhibitor roflumilast","volume":"49","author":"Bethke","year":"2011","journal-title":"Int. J. Clin. Pharm. Ther."},{"key":"10.1016\/j.exppara.2019.107793_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1087057114549735","article-title":"Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits","volume":"20","author":"Blaazer","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.exppara.2019.107793_bib5","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1021\/acs.jmedchem.7b01670","article-title":"Targeting a subpocket in Trypanosoma brucei B1 assists structure-based drug discovery for African sleeping sickness","volume":"61","author":"Blaazer","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107793_bib6","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/jm201148s","article-title":"Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness","volume":"54","author":"Bland","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107793_bib7","first-page":"121","article-title":"PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast","volume":"2","author":"Boswell-Smith","year":"2007","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.exppara.2019.107793_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ijpara.2005.02.005","article-title":"Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt","volume":"35","author":"Botros","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2019.107793_bib9","first-page":"35","article-title":"Screening of a phosphodiesterase (PDE)-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity","volume":"9","author":"Botros","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2019.107793_bib10","first-page":"328","article-title":"Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues","volume":"39","author":"Cheever","year":"1968","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.exppara.2019.107793_bib11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijpara.2004.05.001","article-title":"Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates","volume":"34","author":"Cioli","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2019.107793_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1476-5381.2008.00041.x","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury","volume":"156","author":"Cortijo","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exppara.2019.107793_bib13","series-title":"Prescribing Information","author":"Daliresp (roflumilast) Tablets","year":"2011"},{"key":"10.1016\/j.exppara.2019.107793_bib15","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.bmc.2019.06.026","article-title":"Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)","volume":"27","author":"De Heuvel","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107793_bib14","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/j.bmc.2019.06.027","article-title":"Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors","volume":"27","author":"De Heuvel","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107793_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/ETLS20170113","article-title":"Drug resistance in protozoan parasites","volume":"1","author":"De Koning","year":"2017","journal-title":"Emerg. Topics Life Sci."},{"key":"10.1016\/j.exppara.2019.107793_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir857","article-title":"Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targets","volume":"206","author":"De Koning","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2019.107793_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4269\/ajtmh.1967.16.483","article-title":"Technique for recovering adult schistosomes from laboratory animals","volume":"16","author":"Duvall","year":"1967","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2019.107793_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.aller.2013.07.011","article-title":"Regulation of human skin mast cell histamine release by PDE inhibitors","volume":"43","author":"Eskandari","year":"2015","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.exppara.2019.107793_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan Chung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.exppara.2019.107793_bib22","first-page":"515","article-title":"Cyclic nucleotide signalling in protozoa","volume":"35","author":"Gould","year":"2011","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.exppara.2019.107793_bib23","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/AAC.00508-13","article-title":"Cyclic AMP effectors in African trypanosomes revealed by genome-scale RNAi library screening for resistance to the phosphodiesterase inhibitor Cpd A","volume":"57","author":"Gould","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.107793_bib24","doi-asserted-by":"crossref","first-page":"d2651","DOI":"10.1136\/bmj.d2651","article-title":"Diagnosis and management of schistosomiasis","volume":"342","author":"Gray","year":"2011","journal-title":"Br. Med. J."},{"key":"10.1016\/j.exppara.2019.107793_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s13311-014-0309-7","article-title":"Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease","volume":"12","author":"Gurney","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.exppara.2019.107793_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(24)29537-9","article-title":"Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro","volume":"297","author":"Hatzelmann","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.exppara.2019.107793_bib27","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1371\/journal.pntd.0000412","article-title":"Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden","volume":"3","author":"Hotez","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2019.107793_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neurobiolaging.2014.09.029","article-title":"Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B","volume":"36","author":"Kametani","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exppara.2019.107793_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cellsig.2015.10.005","article-title":"Protein-protein interactions of PDE4 family members - functions, interactions and therapeutic value","volume":"28","author":"Klussmann","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.exppara.2019.107793_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7015-11-96","article-title":"Phosphodiesterase 4-targeted treatments for autoimmune diseases","volume":"11","author":"Kumar","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.exppara.2019.107793_bib31","series-title":"Estudo do modelo Calomys callosus Renger, 1830 (Rodentia: Cricetidae) na infe\u00e7\u00e3o por Schistosoma mansoni Sambon, 1907. Par\u00e2metros parasitol\u00f3gicos e histopatol\u00f3gicos","author":"Lenzi","year":"1998"},{"key":"10.1016\/j.exppara.2019.107793_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40249-015-0071-z","article-title":"High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis","volume":"4","author":"Li","year":"2015","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.exppara.2019.107793_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-003-0636-9","article-title":"Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data","volume":"59","author":"Li","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.exppara.2019.107793_bib34","series-title":"Proceeding of the 1st Sino-American. Symposium","first-page":"34","article-title":"Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles","volume":"1","author":"Liang","year":"1987"},{"key":"10.1016\/j.exppara.2019.107793_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(05)17708-3","article-title":"Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease","volume":"365","author":"Lipworth","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.exppara.2019.107793_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005680","article-title":"Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target","volume":"11","author":"Long","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2019.107793_bib37","first-page":"308213","article-title":"A web portal for gene expression across all life stages of Schistosoma mansoni","author":"Lu","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.exppara.2019.107793_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1645\/GE-52R1","article-title":"The involvement of cyclic adenosine monophosphate in the control of schistosome miracidium cilia","volume":"90","author":"Matsuyama","year":"2004","journal-title":"J. Parasitol."},{"key":"10.1016\/j.exppara.2019.107793_bib40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exppara.2019.107793_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2016.1131127","article-title":"Development of a schistosomiasis vaccine","volume":"15","author":"Molehin","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.exppara.2019.107793_bib42","first-page":"185","article-title":"Repurposing drugs for the treatment and control of helminth infections","volume":"4","author":"Panic","year":"2014","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.exppara.2019.107793_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4269\/ajtmh.1962.11.201","article-title":"New approach to the screening of drugs in experimental schistosomiasis mansoni in mice","volume":"11","author":"Pellegrino","year":"1962","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2019.107793_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"Pica-Mattoccia","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.exppara.2019.107793_bib45","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1371\/journal.pntd.0001455","article-title":"A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni","volume":"6","author":"Protasio","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2019.107793_bib46","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1128\/AAC.46.11.3490-3498.2002","article-title":"Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity","volume":"46","author":"Pyrrho Ados","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.107793_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056867","article-title":"The selective phosphodiesterase 4 inhibitor roflumilast and phosphodiesterase 3\/4 inhibitor pumafentrine reduce clinical score and TNF expression in experimental colitis in mice","volume":"8","author":"Rieder","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2019.107793_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pharmthera.2004.12.001","article-title":"PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression","volume":"106","author":"Sanz","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exppara.2019.107793_bib49","doi-asserted-by":"crossref","first-page":"e00603","DOI":"10.1128\/AAC.00603-18","article-title":"Cyclic nucleotide specific phosphodiesterases as potential drug targets for anti-Leishmania therapy","volume":"62","author":"Sebasti\u00e1n-P\u00e9rez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.107793_bib50","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4155\/fmc-2018-0592","article-title":"Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis","volume":"11","author":"Sebasti\u00e1n-P\u00e9rez","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.exppara.2019.107793_bib51","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4155\/fmc.11.77","article-title":"Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite","volume":"3","author":"Seebeck","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.exppara.2019.107793_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-3-642-17969-3_20","article-title":"Therapeutic potential of phosphodiesterase inhibitors in parasitic diseases","volume":"204","author":"Shakur","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.exppara.2019.107793_bib53","article-title":"Imidazole derivatives as promising agents for the treatment of Chagas disease","volume":"63","author":"Siciliano de Ara\u00fajo","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.107793_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.exppara.2009.12.021","article-title":"The identification of inhibitors of Schistosoma mansoni miracidial transformation by incorporating a medium-throughput small-molecule screen","volume":"125","author":"Taft","year":"2010","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.107793_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphar.2015.00185","article-title":"The ever unfolding story of cAMP signaling in trypanosomatids: vive la difference!","volume":"6","author":"Tagoe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exppara.2019.107793_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2019.107793_bib58","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"Wang","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2019.107793_bib59","series-title":"Progress Report 2001\u20132011 and Strategic Plan 2012\u20132020. Geneva, Switzerland: 2012","author":"WHO","year":"2012"},{"key":"10.1016\/j.exppara.2019.107793_bib60","author":"WHO"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489419303777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489419303777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:26:05Z","timestamp":1758003965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489419303777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":57,"alternative-id":["S0014489419303777"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2019.107793","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2019.107793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107793"}}